Pfizer

• Pfizer CEO says 2023 will be ‘transition year’ as it sees drop in COVID sales

  Pfizer Inc on Tuesday forecast a bigger-than-expected drop in sales of its COVID-19 vaccine and treatment for 2023, intensifying investor concerns over demand for the products.

  Money

  Jan 31
  
• U.S. FDA advisors back bivalent COVID vaccine for initial series, boosters

  Advisers to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of targeting the same coronavirus strain for initial COVID-19 vaccine doses and boosters.

  Health

  Jan 26
  
• Advertisement
• Omicron targeting vaccine now available for Nova Scotia children aged five to 11

  The Omicron-targeting COVID-19 booster shot is now available to children between the ages of five and 11 in Nova Scotia, the province announced Tuesday.

  Health

  Jan 3
• Advertisement
• Bivalent COVID-19 vaccine approved for kids 5-11 in Manitoba

  Health officials announced Tuesday the bivalent COVID vaccine has been approved for kids aged 5-11, saying shots are expected to be available at sites across Manitoba next week.

  Health

  Dec 13, 2022
• Health Canada OKs Pfizer’s bivalent Omicron BA.4/BA.5 booster for kids 5-11

  Health Canada has authorized Pfizer-BioNTech's bivalent COVID-19 vaccine, also known as Comirnaty, for children who are five to 11 years of age. 

  Health

  Dec 9, 2022
• Ontario pharmacists allowed to prescribe Paxlovid for COVID-19 treatment

  Ontario's health minister Sylvia Jones said pharmacists can prescribe Paxlovid to treat severe cases of COVID-19 at no cost to the patient starting on Monday, Dec. 12.

  Health

  Dec 8, 2022
• Health Canada reviews RSV vaccine candidate as cases spike across country

  As doctors worry older adults will be the next wave to become seriously ill by respiratory syncytial virus, Health Canada is reviewing a vaccine to help protect the elderly.

  Health

  Nov 24, 2022
• ‘Get vaccinated’: As flu cases cross seasonal threshold in Canada, experts urge caution

  At the national level, influenza activity has crossed the seasonal threshold of 5.0 per cent positivity, according to a recent report from the Public Health Agency of Canada.

  Health

  Nov 5, 2022
• Advertisement
• Updated Pfizer COVID-19 booster enhances protection, company says

  About 26.3 million Americans have gotten an updated booster since they rolled out in early September, according to the Centers for Disease Control and Prevention.

  World

  Nov 4, 2022
• Advertisement
• Vaccinating pregnant women with new RSV vaccine helped protect newborns: Pfizer

  Pfizer's maternal vaccine is the same recipe it tested successfully in older adults and it plans to seek Food and Drug Administration approval for those vaccinations by year's end.

  World

  Nov 1, 2022